Prasad leads the core team which drives growth and performance at Dr. Reddy’s. He is the architect of the company’s successful Global Generics and API strategies, and has spearheaded Dr. Reddy’s foray into Biosimilars and Differentiated Formulations. His efforts have led the company to a leadership position in the Indian pharmaceutical sector and helped create a significant presence globally, while being recognized for scientific innovation, people practices, and corporate governance.
Prasad serves on the boards of the Indian School of Business, Institute of Life Sciences and Acumen Fund. Causes which are closest to his heart include sustainable development and higher education. The premium Prasad places on sustainability thinking has helped Dr. Reddy’s embrace green technologies and processes, and thereby reduce the company’s ecological footprint.
A Chemical Engineer from the Illinois Institute of Technology in Chicago, Prasad additionally holds a Master’s degree in Industrial Administration from Purdue University, US.